Cancer Investigation, Volume 40, Issue 7 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 40, Issue 7 (2022)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Volume 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Vol 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

Article Commentary

Article Commentary
The Big Data Paradox in Clinical Practice
Pavlos Msaouel
Pages: 567-576
Published online: 08 Jun 2022
AbstractforThe Big Data Paradox in Clinical Practice | Full Text | References | PDF (1.5 MB) | EPUB
  • 7604 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Article

Article
Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022
Sankalp Arora, Palash Asawa, Nilansh Kataria, Lizza E.L. Hendriks & Aakash P. Desai
Pages: 577-589
Published online: 29 Jun 2022
AbstractforManagement of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022 | Full Text | References | PDF (1.2 MB) | EPUB
  • 298 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Three Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Similarities and Differences
Ling Chen, Yangqingqing Zhou, Chaosheng Gan, XiaoLi Wang, Yihui Liu, Chunhui Dong, Ruiyuan He & Jin Yang
Pages: 590-603
Published online: 26 Apr 2022
AbstractforThree Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Similarities and Differences | Full Text | References | PDF (1.2 MB) | EPUB
  • 482 Views
  • 3 CrossRef citations
  • 0Altmetric

Articles

Article
Risk and Prognosis of Second Primary Cancers among Ovarian Cancer Patients, Based on SEER Database
Qi Wang, Tianyu Liu, Chang Liu, Wanyu Wang, Jiabao Zhai, Xu Han, Chuang Nie, Xiyun Ren, Xioajie Zhu, Guanghui Xiang, Haibo Zhou, Wenjing Tian & Xiaomei Li
Pages: 604-620
Published online: 06 Jun 2022
AbstractforRisk and Prognosis of Second Primary Cancers among Ovarian Cancer Patients, Based on SEER Database | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 191 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Survival Advantage of Lymphadenectomy in Patients with Ovarian Cancer
Atanas Ignatov, Sheref Salim Hassan, Stylianos Ivros, Thomas Papathemelis, Zoya Ignatova & Holm Eggemann
Pages: 621-628
Published online: 26 Apr 2022
AbstractforSurvival Advantage of Lymphadenectomy in Patients with Ovarian Cancer | Full Text | References | PDF (735.2 KB) | EPUB
  • 112 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Fear of Cancer Recurrence and COVID-19 Anxiety Among Cancer Survivors: A Cross-Sectional Study in Southeast Iran
Mahlagha Dehghan, Zakieh Namjoo, Fatemeh Mollahoseiny Shekarabadi, Maryam Ziaadini Dashtkhaki, Zahra Karbakhsh Ravari, Fatemeh Kamsari Banani, Fatemeh Kazemi Sarbanani, Behjat Kalantari Khandan & Mohammad Ali Zakeri
Pages: 629-641
Published online: 14 Jul 2022
AbstractforFear of Cancer Recurrence and COVID-19 Anxiety Among Cancer Survivors: A Cross-Sectional Study in Southeast Iran | Full Text | References | PDF (1.1 MB) | EPUB
  • 144 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Uncertainty and Guilt in Ovarian Cancer Survivorship
Dinah A. Tetteh
Pages: 642-653
Published online: 16 Jun 2022
AbstractforUncertainty and Guilt in Ovarian Cancer Survivorship | Full Text | References | PDF (981.7 KB) | EPUB
  • 241 Views
  • 0 CrossRef citations
  • 0Altmetric

Brief Report

Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation
Elizabeth Lerner Papautsky, Martha Carlson, Sheila Marie Johnson, Hannah Montague, Leeann Valero, Deanna J. Attai, R. Donald Harvey, Gary H. Lyman & Maryam Lustberg
Pages: 654-662
Published online: 07 Jul 2022
AbstractforWebinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation | Full Text | References | PDF (1.8 MB) | EPUB
  • 849 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Enhancement of Chemotherapy Efficacy in Cervical Cancer via MAPK Pathway Inhibition by Osimertinib
Yue Hu et al.
Article | Published online: 31 May 2024
Research Progress on CARM1 and its Relationship with Colorectal Cancer
Yuchen Wu et al.
Review Article | Published online: 30 May 2024
Evaluation of the Efficacy of Postoperative Adjuvant Therapy for HER2-Positive Ductal Carcinoma in Situ with Microinvasion
Zhihong Xu et al.
Article | Published online: 24 May 2024
Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort
Wafa Bouleftour et al.
Article | Published online: 24 May 2024
View all latest articles